Cargando…
Linagliptin alleviates fatty liver disease in diabetic db/db mice
AIM: To study the effects of linagliptin on the structural signs of non-alcoholic fatty liver disease (NAFLD) in db/db mice. METHODS: Male diabetic db/db mice (BKS.Cg-Dock7(m+)/(+)Lepr(db)/J) aged 10 wk received the dipeptidyl peptidase 4 (DPP4) inhibitor linagliptin (10 mg/kg) or saline as a placeb...
Autores principales: | Michurina, Svetlana V, Ishenko, Irina Ju, Klimontov, Vadim V, Archipov, Sergey A, Myakina, Natalia E, Cherepanova, Marina A, Zavjalov, Eugenii L, Koncevaya, Galina V, Konenkov, Vladimir I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5107713/ https://www.ncbi.nlm.nih.gov/pubmed/27895822 http://dx.doi.org/10.4239/wjd.v7.i19.534 |
Ejemplares similares
-
Empagliflozin alleviates podocytopathy and enhances glomerular nephrin expression in db/db diabetic mice
por: Klimontov, Vadim V, et al.
Publicado: (2020) -
SGLT2 Inhibitor Empagliflozin and DPP4 Inhibitor Linagliptin Reactivate Glomerular Autophagy in db/db Mice, a Model of Type 2 Diabetes
por: Korbut, Anton I., et al.
Publicado: (2020) -
Apoptosis in the liver of male db/db mice
during the development of obesity and type 2 diabetes
por: Michurina, S.V., et al.
Publicado: (2020) -
Treatment with Autophagy Inducer Trehalose Alleviates Memory and Behavioral Impairments and Neuroinflammatory Brain Processes in db/db Mice
por: Korolenko, Tatiana A., et al.
Publicado: (2021) -
Mibefradil reduces blood glucose concentration in db/db mice
por: Lu, Yujie, et al.
Publicado: (2014)